Frances Correa

Community Oncology Founding Editor Dr. Lee Schwartzberg, spoke with Dr. Joyce O'Shaughnessy at the Oncology Practice Summit in Las Vegas about emerging molecular biomarkers in breast cancer and shares some case-based treatment options to illustrate how these new predictive tools can be used. 

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Schwartzberg was chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.

Community Oncology Founding Editor Dr. Lee Schwartzberg, spoke with Dr. Joyce O'Shaughnessy at the Oncology Practice Summit in Las Vegas about emerging molecular biomarkers in breast cancer and shares some case-based treatment options to illustrate how these new predictive tools can be used. 

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Schwartzberg was chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.

Community Oncology Founding Editor Dr. Lee Schwartzberg, spoke with Dr. Joyce O'Shaughnessy at the Oncology Practice Summit in Las Vegas about emerging molecular biomarkers in breast cancer and shares some case-based treatment options to illustrate how these new predictive tools can be used. 

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Schwartzberg was chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.

Community Oncology Editor Dr. Linda Bosserman spoke with Dr. Rowan Chlebowski at the Oncology Practice Summit in Las Vegas about the effect of diet and exercise on breast cancer patients.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Bosserman was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.

Community Oncology Editor Dr. Linda Bosserman spoke with Dr. Rowan Chlebowski at the Oncology Practice Summit in Las Vegas about the effect of diet and exercise on breast cancer patients.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Bosserman was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.

Community Oncology Editor Dr. Linda Bosserman spoke with Dr. Rowan Chlebowski at the Oncology Practice Summit in Las Vegas about the effect of diet and exercise on breast cancer patients.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Bosserman was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.

Community Oncology editor Dr. David Henry spoke with Dr. Kenneth Anderson at the Oncology Practice Summit in Las Vegas about the antibody elotuzumab in the treatment of relapsed or refractory multiple myeloma. He notes that as a single agent, the anti-CS humanized monoclonal antibody can achieve stable disease and when used in combination with lenalidomide and low-dose dexamethasone early findings suggest a response rate of 80%-90% and a near doubling of progression-free survival.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Henry was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology, and The Oncology Report.

Community Oncology editor Dr. David Henry spoke with Dr. Kenneth Anderson at the Oncology Practice Summit in Las Vegas about the antibody elotuzumab in the treatment of relapsed or refractory multiple myeloma. He notes that as a single agent, the anti-CS humanized monoclonal antibody can achieve stable disease and when used in combination with lenalidomide and low-dose dexamethasone early findings suggest a response rate of 80%-90% and a near doubling of progression-free survival.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Henry was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology, and The Oncology Report.

Community Oncology editor Dr. David Henry spoke with Dr. Kenneth Anderson at the Oncology Practice Summit in Las Vegas about the antibody elotuzumab in the treatment of relapsed or refractory multiple myeloma. He notes that as a single agent, the anti-CS humanized monoclonal antibody can achieve stable disease and when used in combination with lenalidomide and low-dose dexamethasone early findings suggest a response rate of 80%-90% and a near doubling of progression-free survival.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Henry was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology, and The Oncology Report.

Mr. William Goeren provides personal insight and practical tips for communicating with cancer patients using the SPIKES method. Mr. Goeren is a recent cancer survivor and director of clinical services at CancerCare, a national nonprofit organization that provides counseling, educational programs, and practical and financial assistance to people affected by cancer.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice. The conference was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.

Mr. William Goeren provides personal insight and practical tips for communicating with cancer patients using the SPIKES method. Mr. Goeren is a recent cancer survivor and director of clinical services at CancerCare, a national nonprofit organization that provides counseling, educational programs, and practical and financial assistance to people affected by cancer.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice. The conference was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.

Mr. William Goeren provides personal insight and practical tips for communicating with cancer patients using the SPIKES method. Mr. Goeren is a recent cancer survivor and director of clinical services at CancerCare, a national nonprofit organization that provides counseling, educational programs, and practical and financial assistance to people affected by cancer.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice. The conference was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.

Parental presence in the exam room can sometimes mean more harm than good. In a recent survey by the National Foundation for Infectious Diseases (NFID), 84% of physicians said teenagers are more likely to ask about concerns with weight management, sexual health, vaccines, and stress if teens and doctors have more one-on-one time.

Teenagers may also care more about their health than their physicians think. Nearly 70% of teens said they worry about being healthy, and only 7% of physicians thought teens wanted to be proactive about their health. Regardless, millions of teens might be missing the opportunity for regular checks and screening for potential health risks, according to data from the U.S. Department of Health and Human Services and the U.S. Census.
At a recent NFID briefing releasing survey results, experts offered some tips for how to best connect with teen patients.

Watch our video to find out more:

Parental presence in the exam room can sometimes mean more harm than good. In a recent survey by the National Foundation for Infectious Diseases (NFID), 84% of physicians said teenagers are more likely to ask about concerns with weight management, sexual health, vaccines, and stress if teens and doctors have more one-on-one time.

Teenagers may also care more about their health than their physicians think. Nearly 70% of teens said they worry about being healthy, and only 7% of physicians thought teens wanted to be proactive about their health. Regardless, millions of teens might be missing the opportunity for regular checks and screening for potential health risks, according to data from the U.S. Department of Health and Human Services and the U.S. Census.
At a recent NFID briefing releasing survey results, experts offered some tips for how to best connect with teen patients.

Watch our video to find out more:

Parental presence in the exam room can sometimes mean more harm than good. In a recent survey by the National Foundation for Infectious Diseases (NFID), 84% of physicians said teenagers are more likely to ask about concerns with weight management, sexual health, vaccines, and stress if teens and doctors have more one-on-one time.

Teenagers may also care more about their health than their physicians think. Nearly 70% of teens said they worry about being healthy, and only 7% of physicians thought teens wanted to be proactive about their health. Regardless, millions of teens might be missing the opportunity for regular checks and screening for potential health risks, according to data from the U.S. Department of Health and Human Services and the U.S. Census.
At a recent NFID briefing releasing survey results, experts offered some tips for how to best connect with teen patients.

Watch our video to find out more:

Community Oncology Editor-in-Chief Dr. David Henry spoke with Dr. Nicholas Vogelzang at the Oncology Practice Summit in Las Vegas about how he treats patients with metastatic prostate cancer given the new agents that are now available and growing concerns about treatment costs and patient quality of life.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Henry was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.
 

Community Oncology Editor-in-Chief Dr. David Henry spoke with Dr. Nicholas Vogelzang at the Oncology Practice Summit in Las Vegas about how he treats patients with metastatic prostate cancer given the new agents that are now available and growing concerns about treatment costs and patient quality of life.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Henry was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.
 

Community Oncology Editor-in-Chief Dr. David Henry spoke with Dr. Nicholas Vogelzang at the Oncology Practice Summit in Las Vegas about how he treats patients with metastatic prostate cancer given the new agents that are now available and growing concerns about treatment costs and patient quality of life.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Henry was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.
 

Community Oncology Editor-in-Chief Dr. David Henry spoke with Dr. Corey Langer at the Oncology Practice Summit in Las Vegas about which lung cancer patients are eligible for bevacizumab therapy, maintenance therapy, and the latest on erlotinib therapy for EGFR-mutated patients.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Henry was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.

Community Oncology Editor-in-Chief Dr. David Henry spoke with Dr. Corey Langer at the Oncology Practice Summit in Las Vegas about which lung cancer patients are eligible for bevacizumab therapy, maintenance therapy, and the latest on erlotinib therapy for EGFR-mutated patients.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Henry was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.

Community Oncology Editor-in-Chief Dr. David Henry spoke with Dr. Corey Langer at the Oncology Practice Summit in Las Vegas about which lung cancer patients are eligible for bevacizumab therapy, maintenance therapy, and the latest on erlotinib therapy for EGFR-mutated patients.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Henry was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.

Community Oncology Editor-in-Chief Dr. David Henry spoke with Dr. Jorge Cortes at the Oncology Practice Summit in Las Vegas about prognostic markers in chronic lymphocytic leukemia.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Henry was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.

Community Oncology Editor-in-Chief Dr. David Henry spoke with Dr. Jorge Cortes at the Oncology Practice Summit in Las Vegas about prognostic markers in chronic lymphocytic leukemia.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Henry was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.

Community Oncology Editor-in-Chief Dr. David Henry spoke with Dr. Jorge Cortes at the Oncology Practice Summit in Las Vegas about prognostic markers in chronic lymphocytic leukemia.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Henry was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.

Community Oncology Editor Dr. Debra Patt spoke with Dr. Ezra Cohen at the Oncology Practice Summit in Las Vegas about the HPV epidemic and its effect on the pathophysiology and treatment of head and neck cancers.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Patt was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.

Community Oncology Editor Dr. Debra Patt spoke with Dr. Ezra Cohen at the Oncology Practice Summit in Las Vegas about the HPV epidemic and its effect on the pathophysiology and treatment of head and neck cancers.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Patt was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.

Community Oncology Editor Dr. Debra Patt spoke with Dr. Ezra Cohen at the Oncology Practice Summit in Las Vegas about the HPV epidemic and its effect on the pathophysiology and treatment of head and neck cancers.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Patt was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.

Community Oncology Editor Dr. Jame Abraham spoke with Dr. George Kim at the Oncology Practice Summit in Las Vegas about the new developments in treating colon and GI cancers.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Abraham was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.
 

Community Oncology Editor Dr. Jame Abraham spoke with Dr. George Kim at the Oncology Practice Summit in Las Vegas about the new developments in treating colon and GI cancers.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Abraham was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.
 

Community Oncology Editor Dr. Jame Abraham spoke with Dr. George Kim at the Oncology Practice Summit in Las Vegas about the new developments in treating colon and GI cancers.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice.  Dr. Abraham was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.